NAD+ — Research Background

NAD+ levels decline with age, and this decline has been associated with reduced mitochondrial function and increased cellular stress. Research into NAD+ supplementation — particularly via IV administration — has accelerated in parallel with the growth of the longevity medicine sector. European longevity clinics increasingly offer NAD+ IV infusion protocols as part of broader anti-aging programs.

Clinical Applications

• Longevity Clinics: Core compound in cellular energy and mitochondrial function protocols. Typically administered via IV infusion in 500mg–1,000mg doses.
• Metabolic Health: Researched in the context of metabolic syndrome, insulin sensitivity, and mitochondrial dysfunction.
• Neurological Research: Studied for neuroprotective properties and cognitive function in aging populations.
• TRT / Hormone Programs: Frequently stacked with GH peptides (Tesamorelin/Ipamorelin) in comprehensive longevity protocols.

Why Clinics Source NAD+ Wholesale

NAD+ IV protocols typically require 500–1,000mg per session. At clinic scale — 10+ sessions per week — retail procurement is not viable. Wholesale supply with consistent lot quality, proper documentation (CoA, SDS), and reliable EU logistics is the only practical solution for clinic-scale use.